Cargando…

Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer

SIMPLE SUMMARY: Breast cancer is the leading cause of female cancer-related deaths worldwide. New technologies with enhanced sensitivity and specificity for early diagnosis and tailored monitoring are in critical demand. Thus, metabolomics appears to be a growing tool in order to detect molecular di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díaz-Beltrán, Leticia, González-Olmedo, Carmen, Luque-Caro, Natalia, Díaz, Caridad, Martín-Blázquez, Ariadna, Fernández-Navarro, Mónica, Ortega-Granados, Ana Laura, Gálvez-Montosa, Fernando, Vicente, Francisca, Pérez del Palacio, José, Sánchez-Rovira, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795819/ https://www.ncbi.nlm.nih.gov/pubmed/33466323 http://dx.doi.org/10.3390/cancers13010147

Ejemplares similares

Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach
por: Díaz, Caridad, et al.
Publicado: (2022)

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020)

Novel Biomarkers to Distinguish between Type 3c and Type 2 Diabetes Mellitus by Untargeted Metabolomics
por: Jimenez-Luna, Cristina, et al.
Publicado: (2020)

Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2019)

Untargeted Metabolomics for the Diagnosis of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis
por: Díaz, Caridad, et al.
Publicado: (2021)

Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission
por: Sánchez-Rovira, Pedro, et al.
Publicado: (2021)

Metabolomic profile of cancer stem cell‐derived exosomes from patients with malignant melanoma
por: Palacios‐Ferrer, José Luis, et al.
Publicado: (2020)

Exploring the Role of CYP3A4 Mediated Drug Metabolism in the Pharmacological Modulation of Nitric Oxide Production
por: Pérez-del Palacio, José, et al.
Publicado: (2017)

Identification of Compounds with Potential Therapeutic Uses from Sweet Pepper (Capsicum annuum L.) Fruits and Their Modulation by Nitric Oxide (NO)
por: Guevara, Lucía, et al.
Publicado: (2021)

Widespread rash in lung adenocarcinoma
por: Gálvez-Montosa, Fernando, et al.
Publicado: (2018)

TFG-β Nuclear Staining as a Potential Relapse Risk Factor in Early-Stage Non-Small-Cell Lung Cancer
por: Cárdenas-Quesada, Nuria, et al.
Publicado: (2022)

The role of services content for manufacturing competitiveness: A network analysis
por: Blázquez, Leticia, et al.
Publicado: (2020)

Functional metabolomics: from biomarker discovery to metabolome reprogramming
por: Peng, Bo, et al.
Publicado: (2015)

Metabolomics and Biomarkers for Drug Discovery
por: Yeung, Pollen K.
Publicado: (2018)

Insights into the Pharmacokinetics and In Vitro Cell-Based Studies of the Imidazoline I(2) Receptor Ligand B06
por: Bagán, Andrea, et al.
Publicado: (2022)

Discovery and validation of breast cancer subtypes
por: Kapp, Amy V, et al.
Publicado: (2007)

Discovery and validation of breast cancer subtypes
por: Kapp, Amy V, et al.
Publicado: (2006)

Regulation of the Expression of the β-Lactam Antibiotic-Resistance Determinants in Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Blázquez, Blas, et al.
Publicado: (2014)

Analysis of the mortality rate in patients admitted to the ICU for severe community-acquired pneumonia
por: Joya-Montosa, C, et al.
Publicado: (2015)

Ultra-Performance Liquid Chromatography-Ion Mobility Separation-Quadruple Time-of-Flight MS (UHPLC-IMS-QTOF MS) Metabolomics for Short-Term Biomarker Discovery of Orange Intake: A Randomized, Controlled Crossover Study
por: Lacalle-Bergeron, Leticia, et al.
Publicado: (2020)

Proteomic and metabolomic approaches to biomarker discovery
por: Issaq, Haleem J, et al.
Publicado: (2019)

Metabolomics shows the way to new discoveries
por: Goodacre, Royston
Publicado: (2005)

Metabolomics for Biomarker Discovery in Gastroenterological Cancer
por: Nishiumi, Shin, et al.
Publicado: (2014)

Metabolomics for Biomarker Discovery: Moving to the Clinic
por: Zhang, Aihua, et al.
Publicado: (2015)

Metabolomics in infectious diseases and drug discovery
por: Tounta, Vivian, et al.
Publicado: (2021)

Biomarker discovery for tuberculosis using metabolomics
por: Yu, Yi, et al.
Publicado: (2023)

Usefulness of [Formula: see text] Kinetics and Biomechanical Parameters as Predictors of Athlete’s Performance in 800 m Running Race
por: Navarro, Vicente Torres, et al.
Publicado: (2023)

Discovery of New Molecular Subtypes in Oesophageal Adenocarcinoma
por: Berg, Daniela, et al.
Publicado: (2011)

Metabolomics of Chlorophylls and Carotenoids: Analytical Methods and Metabolome-Based Studies
por: Roca, María, et al.
Publicado: (2021)

The Metabolomic Profile of Lymphoma Subtypes: A Pilot Study
por: Barberini, Luigi, et al.
Publicado: (2019)

Metabolomics-Based Discovery of Diagnostic Biomarkers for Onchocerciasis
por: Denery, Judith R., et al.
Publicado: (2010)

The metabolome identity: basis for discovery of biomarkers in neurodegeneration
por: Bourgognon, Julie-Myrtille, et al.
Publicado: (2019)

Metabolomics Contributions to the Discovery of Prostate Cancer Biomarkers
por: Gómez-Cebrián, Nuria, et al.
Publicado: (2019)

The biomarkers discovery of hyperuricemia and gout: proteomics and metabolomics
por: Wu, Xinghong, et al.
Publicado: (2023)

Application of metabolomics in urolithiasis: the discovery and usage of succinate
por: Zhang, Xiu-zhen, et al.
Publicado: (2023)

New Ikarugamycin Derivatives with Antifungal and Antibacterial Properties from Streptomyces zhaozhouensis
por: Lacret, Rodney, et al.
Publicado: (2014)

The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy
por: Pérez, Irene, et al.
Publicado: (2022)

Latin American databases of natural products: biodiversity and drug discovery against SARS-CoV-2
por: Núñez, Marvin J., et al.
Publicado: (2021)

Integrative Subtype Discovery in Glioblastoma Using iCluster
por: Shen, Ronglai, et al.
Publicado: (2012)

Discovery and molecular basis of subtype-selective cyclophilin inhibitors
por: Peterson, Alexander A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ekcq5ov4j3hbpgvan5muj2f0v